These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 22427664

  • 1. Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes.
    Ortiz C, Caja L, Bertran E, Gonzalez-Rodriguez Á, Valverde ÁM, Fabregat I, Sancho P.
    J Biol Chem; 2012 May 04; 287(19):15263-74. PubMed ID: 22427664
    [Abstract] [Full Text] [Related]

  • 2. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY, Hu YC, He XR, Wang Y, Song BQ, Zhou PK, Zhu MX, Li G, Wu DC.
    Cell Biol Toxicol; 2007 Mar 04; 23(2):113-28. PubMed ID: 17096210
    [Abstract] [Full Text] [Related]

  • 3. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
    García-Ruiz I, Blanes Ruiz N, Rada P, Pardo V, Ruiz L, Blas-García A, Valdecantos MP, Grau Sanz M, Solís Herruzo JA, Valverde ÁM.
    Redox Biol; 2019 Sep 04; 26():101263. PubMed ID: 31299613
    [Abstract] [Full Text] [Related]

  • 4. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
    Moreno-Càceres J, Mainez J, Mayoral R, Martín-Sanz P, Egea G, Fabregat I.
    FEBS J; 2016 Apr 04; 283(7):1300-10. PubMed ID: 26815118
    [Abstract] [Full Text] [Related]

  • 5. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
    Qin Z, Xia W, Fisher GJ, Voorhees JJ, Quan T.
    Cell Commun Signal; 2018 Apr 25; 16(1):18. PubMed ID: 29695252
    [Abstract] [Full Text] [Related]

  • 6. Polarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-catenin.
    Zhang M, Lee CH, Luo DD, Krupa A, Fraser D, Phillips A.
    J Biol Chem; 2007 Sep 28; 282(39):28639-28647. PubMed ID: 17623674
    [Abstract] [Full Text] [Related]

  • 7. Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
    Altomare D, Velidandla R, Pirisi L, Creek KE.
    BMC Cancer; 2013 Sep 18; 13():424. PubMed ID: 24047375
    [Abstract] [Full Text] [Related]

  • 8. Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity.
    Mobasher MA, González-Rodriguez A, Santamaría B, Ramos S, Martín MÁ, Goya L, Rada P, Letzig L, James LP, Cuadrado A, Martín-Pérez J, Simpson KJ, Muntané J, Valverde AM.
    Cell Death Dis; 2013 May 09; 4(5):e626. PubMed ID: 23661004
    [Abstract] [Full Text] [Related]

  • 9. Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells.
    Taheripak G, Bakhtiyari S, Rajabibazl M, Pasalar P, Meshkani R.
    Free Radic Biol Med; 2013 Dec 09; 65():1435-1446. PubMed ID: 24120971
    [Abstract] [Full Text] [Related]

  • 10. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death.
    Carmona-Cuenca I, Herrera B, Ventura JJ, Roncero C, Fernández M, Fabregat I.
    J Cell Physiol; 2006 May 09; 207(2):322-30. PubMed ID: 16331683
    [Abstract] [Full Text] [Related]

  • 11. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R, Dobberfuhl AD, Cooley C, Overstreet JM, Patel S, Goldschmeding R, Meldrum KK, Higgins PJ.
    Cell Signal; 2013 Nov 09; 25(11):2198-209. PubMed ID: 23872073
    [Abstract] [Full Text] [Related]

  • 12. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM, Valverde AM.
    Endocrinology; 2007 Feb 09; 148(2):594-608. PubMed ID: 17068137
    [Abstract] [Full Text] [Related]

  • 13. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.
    Zhenye L, Chuzhong L, Youtu W, Xiaolei L, Lei C, Lichuan H, Hongyun W, Yonggang W, Fei W, Yazhuo Z.
    J Transl Med; 2014 Mar 18; 12():71. PubMed ID: 24636138
    [Abstract] [Full Text] [Related]

  • 14. Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/Smad signaling.
    Li X, Zhang L, Yin X, Gao Z, Zhang H, Liu X, Pan X, Li N, Yu Z.
    Toxicol Lett; 2014 Mar 03; 225(2):208-15. PubMed ID: 24374174
    [Abstract] [Full Text] [Related]

  • 15. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.
    Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C.
    Oncogene; 2013 Mar 21; 32(12):1549-59. PubMed ID: 22641218
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
    Piao S, Choi MJ, Tumurbaatar M, Kim WJ, Jin HR, Shin SH, Tuvshintur B, Yin GN, Song JS, Kwon MH, Lee SJ, Han JY, Kim SJ, Ryu JK, Suh JK.
    J Sex Med; 2010 Oct 21; 7(10):3385-95. PubMed ID: 20233292
    [Abstract] [Full Text] [Related]

  • 19. TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation.
    Yu L, Lin Q, Liao H, Feng J, Dong X, Ye J.
    Cell Physiol Biochem; 2010 Oct 21; 26(6):869-78. PubMed ID: 21220918
    [Abstract] [Full Text] [Related]

  • 20. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE.
    Oncogene; 2003 Jan 23; 22(3):412-25. PubMed ID: 12545162
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.